NOVAVAX INC — Director's Dealing 2014

Mar 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2014-03-25

Reporting Person: DOUGLAS RICHARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-25	Common Stock	P	50000	$4.334	Acquired	250000	Direct

Footnotes

F1: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.305 to $4.39, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.